2001
DOI: 10.1034/j.1398-9995.2001.00137.x
|View full text |Cite
|
Sign up to set email alerts
|

The role of CD30 in atopic disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
31
1

Year Published

2007
2007
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(33 citation statements)
references
References 109 publications
(165 reference statements)
1
31
1
Order By: Relevance
“…In parallel, in a similar approach using a model of atopic conjunctivitis, treatment with an agonistic anti-4-1BB before or after sensitization abolished the development of allergic conjunctivitis [29]. For CD30, several studies have shown indirect evidence for a role in allergic diseases by correlating CD30 expression and sCD30 levels to severity and outcome of allergic asthma and atopic dermatitis [31][32][33]. By using CD30 −/− mice and mAbs directed against CD30 receptor or ligand, we could directly demonstrate a critical role of CD30 signalling in the development of asthma [16,17].…”
Section: Discussionmentioning
confidence: 94%
“…In parallel, in a similar approach using a model of atopic conjunctivitis, treatment with an agonistic anti-4-1BB before or after sensitization abolished the development of allergic conjunctivitis [29]. For CD30, several studies have shown indirect evidence for a role in allergic diseases by correlating CD30 expression and sCD30 levels to severity and outcome of allergic asthma and atopic dermatitis [31][32][33]. By using CD30 −/− mice and mAbs directed against CD30 receptor or ligand, we could directly demonstrate a critical role of CD30 signalling in the development of asthma [16,17].…”
Section: Discussionmentioning
confidence: 94%
“…There are several lines of evidence showing that the CD30L-CD30 signaling is involved in Th2 cell responses and Th2-associated diseases (15)(16)(17)(18). Treating OVA-immunized WT mice with anti-CD153 mAb resulted in significantly reduced airway inflammation, serum IgE and Th2 cytokine levels.…”
Section: Discussionmentioning
confidence: 99%
“…CD30, the receptor for CD30L, and belonging to the TNFRSF, was reported to be expressed preferentially by activated or memory Th2 cells but not by resting B or T cells (12)(13)(14). CD30L/CD30 signaling was thought to be involved in Th2 cell responses and Th2-associated diseases (15)(16)(17)(18). However, a number of recent studies suggested that CD30L/CD30 signaling is also linked to Th1 cell responses and Th1-associated diseases (19 -22).…”
mentioning
confidence: 99%
“…These results suggested that CD30L/CD30 signaling is linked to Th1 cell responses and Th1-associated diseases. However, there are several observations that CD30L/CD30 signaling is involved in Th2 cell responses (39,40) and in naturally occurring Treg responses (23,24). Thus, CD30 signaling may not be linked to a commitment step for the differentiation of a specific Th cell subset.…”
Section: /2mentioning
confidence: 99%